In February 2014, Merck Sharp & Dohme Corp. (“MSD”) brought proceedings against Paranova Läkemedel AB (“Paranova”), alleging that Paranova was violating MSD’s right as an exclusive licensee of the European patent EP 0 595 935 (“EP 935”) by taking preparatory measures for parallel importation. MSD applied for a permanent injunction and corrective measures as well as a preliminary injunction. The Stockholm District Court granted a permanent injunction and held that the approved application for authorization of parallel importation from the European Medicines Agency (EMA) was considered to constitute imminent infringement.

A full summary of this case has been published on Kluwer IP Law.


Kluwer IP Law
This page as PDF